Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR protocol T

Charles C. Wykoff, Seenu M. Hariprasad

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR protocol T'. Together they form a unique fingerprint.